tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kristen Kluska, 320 are a BUY (91.95%), 28 are a HOLD (8.05%).
Analyst Kristen Kluska, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 33.73% that have a potential upside of 34.49% achieved within 107 days.
Kristen Kluska’s has documented 663 price targets and ratings displayed on 54 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on IRON, Disc Medicine.
Analyst best performing recommendations are on QURE (UNIQURE NV).
The best stock recommendation documented was for QURE (UNIQURE NV) at 9/22/2025. The price target of $47 was fulfilled within 2 days with a profit of $33.17 (239.84%) receiving and performance score of 1199.2.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Jun-2014
$64
$36.47 (132.47%)
$64
21 days ago
(02-Oct-2026)
8/38 (21.05%)
$32.35 (102.21%)
278
Buy Since 20-Mar-2025
$57
$29.47 (107.05%)
$50
1 months ago
(23-Sep-2026)
2/6 (33.33%)
$25.88 (83.16%)
237
Buy Since 10-Sep-2021
$88
$60.47 (219.65%)
$78
1 months ago
(23-Sep-2026)
0/4 (0%)
$56.88 (182.78%)
Buy Since 20-Feb-2020
$72
$44.47 (161.53%)
$61
1 months 1 days ago
(22-Sep-2026)
5/24 (20.83%)
$38.49 (114.86%)
72
Buy Since 08-May-2026
$53
$25.47 (92.52%)
$48
2 months 16 days ago
(07-Aug-2026)
4/8 (50%)
$11.29 (27.07%)
33
Which stock is Kristen Kluska most bullish on?
Which stock is Kristen Kluska most reserved on?
What Year was the first public recommendation made by Kristen Kluska?
